Golden State Medical Supply Inc. recalls Carbamazepine Tablets
- Recalling company
- Golden State Medical Supply Inc.
- Product
- Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
- Reason
- CGMP deviations: tablets with black specks.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Aug 7, 2026
- Reported
- Aug 26, 2026
- Distribution
- USA Nationwide
- Status
- Ongoing
- Quantity
- 1200 bottles
- Lot / codes
- Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Company location
- Camarillo, CA
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0771-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0771-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.